LECTRA: Lectra and Aubade announce De Monfort University

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
LECTRA: Lectra and Aubade announce De Monfort University student lingerie contest results

Lectra and Aubade announce De Monfort University student lingerie contest results

Lectra and Aubade working together to prepare future designers and pattern makers  

PARIS, Jan. 22, 2015 (GLOBE NEWSWIRE) -- Lectra, the world leader in integrated technology solutions dedicated to industries using soft materials-fabrics, leather, technical textiles and composite materials-and Aubade, the renowned French lingerie brand have announced the results of the Lectra/Aubade 2014 competition. The award shines the spotlight on design and pattern making students from De Monfort University (DMU), UK by tasking students with designing a small lingerie collection that reflects the Aubade brand. Students were required to both design and develop their collections with Lectra's product development solution, Modaris ® .

The inaugural edition of this was open to final-year DMU students. The aim is to get students to develop a 6-piece collection using Lectra's pattern making solution Modaris, underlining the famous lingerie brand's DNA, and within the theme of English handwriting. The jury decided to award two students instead of just the one as initially planned because of the exceptional creativity and execution of design. Aubade is pleased to welcome both Ellie Balwako and Hannah Jones, from beginning summer 2015, for 6 month internships in Paris. The first student won for product development and the second one won for design and their internships will reflect this.

"The competition is a reflection of Lectra's commitment to education, Aubade's involvement in transmitting the brand's DNA and DMU's efforts to favor their students' employability," explains Anastasia Charbin, Fashion and Apparel Marketing Director, Lectra.

"This contest with one of Lectra's education partners represents a great opportunity to meet promising talent, who are immediately operational," underlines Annie Bureau, Operations Director at Aubade. "De Monfort University has a lingerie program which is specifically adapted to industry needs; students are trained on Lectra's pattern-making solution, which we've used for years," says Marie-Béatrice Pereira, Development office Manager at Aubade.

"This contest is a true opportunity for our final-year students who were really motivated. They've demonstrated great creativity, drawing from Aubade's brand spirit and concentrating on technical aspects to obtain a perfect fit. They used Lectra solutions, which are at the core of our program and which are an undeniable advantage when looking for a job," explains Gillian Proctor, Principal Lecturer & Programme and Leader for Contour Fashion.

"This is the story of a wonderful project between Lectra, De Monfort University and Aubade. It is a true exchange between professionals and students. We are very pleased to welcome and to work with young talent who bring a fresh eye and their unique personalities to the Aubade team," concludes Claire Masson, global brand Director at Aubade.

Founded in 1947, De Monfort University's 3-year curriculum called "Contour Fashion" is the oldest lingerie diploma in the world. Students are trained on Lectra's Modaris it is extremely powerful for lingerie, corsetry, activewear, swimwear and underwear.

® Modaris is a registered trademark of Lectra.  

About Aubade

Founded in 1875 by corset specialist Dr. Bernard, the Aubade brand was created in 1958. Aubade is a high-end lingerie brand, an ode to femininity and its seductive power. A symbol of French elegance and sophistication, the company's history has been peppered with innovation, discovery, boldness and transformation. Aubade's strength and identity comes from its focus on luxurious fabrics and products that are beautiful to look at, in fashionable, bright colors. Aubade's "Lessons in Seduction", launched in 1992, have taught women how to master the art of seduction, giving them fun, playful tips on how to titillate the men in their lives!

About Lectra

Lectra is the world leader in integrated technology solutions that automate, streamline and accelerate product design, development and manufacturing processes for industries using soft materials. Lectra develops the most advanced specialized software and cutting systems and provides associated services to a broad array of markets including fashion (apparel, accessories, footwear), automotive (car seats and interiors, airbags), furniture, as well as a wide variety of other market sectors, such as aeronautical and marine industries, wind power, and personal protective equipment. Lectra serves 23,000 customers in more than 100 countries with 1,500 employees and $270 million in 2013 revenues. The company is listed on Euronext.

For more information, please visit www.lectra.com

Contact - Lectra Headquarters / Press Dept.: Nathalie Fournier-Christol

E-mail: n.fournier-christol@lectra.com
Tel.: +33 (0)1 53 64 42 37 - Fax: +33 (0)1 53 64 43 40

Lectra_Aubade_DeMonfort http://hugin.info/143494/R/1888963/668537.pdf

HUG#1888963

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading